Related Experiment Video
Updated: Jun 10, 2026
19:57
An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
HIV clinical pharmacists--the US perspective
J D Scott1, K A Abernathy, M Diaz-Linares
1Pharmacy Practice and Administration, Western University of Health Sciences College of Pharmacy, Pomona, USA. jdscott@westernu.edu
Summary
Clinical pharmacists play a vital role in managing HIV/AIDS care, evolving from hospital-based infectious disease specialists to ambulatory care experts. Their contributions impact adherence and cost-effectiveness, though clinical outcome improvements require further study.
Area of Science:
- Pharmacology
- Infectious Diseases
- Public Health
Background:
- Clinical pharmacists have been integral to HIV/AIDS treatment since the epidemic's onset.
- Their roles have transitioned from inpatient infectious disease management to specialized ambulatory care for HIV patients.
Purpose of the Study:
- To review published data on the roles and benefits of clinical pharmacists in HIV treatment.
- To showcase diverse examples of US clinical pharmacists specializing in HIV care across various settings and patient populations.
Main Methods:
- Literature review of published data on clinical pharmacists in HIV/AIDS treatment.
- Case examples of clinical pharmacists in diverse US practice settings (free-clinics, government clinics, academic institutions, healthcare systems).
Main Results:
- Documented improvements in patient adherence and cost savings associated with clinical pharmacist involvement.
- Challenges in identifying significant clinical outcome improvements (viral load, CD4 counts) due to small study sizes.
Conclusions:
- Clinical pharmacists demonstrate value in HIV/AIDS management through improved adherence and cost-effectiveness.
- The diverse roles and settings of HIV-focused clinical pharmacists highlight their adaptability and importance in patient care.
Related Concept Videos
01:17Healthcare Agencies II
There are various healthcare agencies in the United States—some of which are managed by religious institutions and others by different government branches.
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
Parish nursing is a growing specialty nursing profession that focuses on holistic healthcare, health promotion, and illness prevention. It blends professional nursing practice with a health ministry, focusing on health and healing within the context of a Christian community. Parish nurses serve as health educators, referral sources, and lay...
01:26Drug Administration and Therapy Phases: Overview
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
01:11Clinical Trials: Overview
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:10Retrovirus Life Cycles
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the retrovirus to...
01:26Pharmacokinetics in Pediatric Patients: Drug Excretion
In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...